Common genetic polymorphisms contribute to the association between chronic lymphocytic leukaemia and non-melanoma skin cancer
- PMID: 33748835
- PMCID: PMC8521875
- DOI: 10.1093/ije/dyab042
Common genetic polymorphisms contribute to the association between chronic lymphocytic leukaemia and non-melanoma skin cancer
Abstract
Background: Epidemiological studies have demonstrated a positive association between chronic lymphocytic leukaemia (CLL) and non-melanoma skin cancer (NMSC). We hypothesized that shared genetic risk factors between CLL and NMSC could contribute to the association observed between these diseases.
Methods: We examined the association between (i) established NMSC susceptibility loci and CLL risk in a meta-analysis including 3100 CLL cases and 7667 controls and (ii) established CLL loci and NMSC risk in a study of 4242 basal cell carcinoma (BCC) cases, 825 squamous cell carcinoma (SCC) cases and 12802 controls. Polygenic risk scores (PRS) for CLL, BCC and SCC were constructed using established loci. Logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs).
Results: Higher CLL-PRS was associated with increased BCC risk (OR4th-quartile-vs-1st-quartile = 1.13, 95% CI: 1.02-1.24, Ptrend = 0.009), even after removing the shared 6p25.3 locus. No association was observed with BCC-PRS and CLL risk (Ptrend = 0.68). These findings support a contributory role for CLL in BCC risk, but not for BCC in CLL risk. Increased CLL risk was observed with higher SCC-PRS (OR4th-quartile-vs-1st-quartile = 1.22, 95% CI: 1.08-1.38, Ptrend = 1.36 × 10-5), which was driven by shared genetic susceptibility at the 6p25.3 locus.
Conclusion: These findings highlight the role of pleiotropy regarding the pathogenesis of CLL and NMSC and shows that a single pleiotropic locus, 6p25.3, drives the observed association between genetic susceptibility to SCC and increased CLL risk. The study also provides evidence that genetic susceptibility for CLL increases BCC risk.
Keywords: CLL; NMSC; pleiotropy; polygenic risk score.
Published by Oxford University Press on behalf of the International Epidemiological Association 2021. This work is written by US Government employees and is in the public domain in the US.
Similar articles
-
Genome-wide association studies and polygenic risk scores for skin cancer: clinically useful yet?Br J Dermatol. 2019 Dec;181(6):1146-1155. doi: 10.1111/bjd.17917. Epub 2019 Jul 7. Br J Dermatol. 2019. PMID: 30908599 Free PMC article. Review.
-
Delineation of clinical and biological factors associated with cutaneous squamous cell carcinoma among patients with chronic lymphocytic leukemia.J Am Acad Dermatol. 2020 Dec;83(6):1581-1589. doi: 10.1016/j.jaad.2020.06.1024. Epub 2020 Jul 16. J Am Acad Dermatol. 2020. PMID: 32682027 Free PMC article.
-
Non-Hodgkin's lymphomas, chronic lymphocytic leukaemias and skin cancers.Br J Cancer. 1996 Dec;74(11):1847-50. doi: 10.1038/bjc.1996.642. Br J Cancer. 1996. PMID: 8956805 Free PMC article.
-
Height, height-related SNPs, and risk of non-melanoma skin cancer.Br J Cancer. 2017 Jan 3;116(1):134-140. doi: 10.1038/bjc.2016.366. Epub 2016 Nov 15. Br J Cancer. 2017. PMID: 27846199 Free PMC article.
-
UV-Induced Molecular Signaling Differences in Melanoma and Non-melanoma Skin Cancer.Adv Exp Med Biol. 2017;996:27-40. doi: 10.1007/978-3-319-56017-5_3. Adv Exp Med Biol. 2017. PMID: 29124688 Review.
Cited by
-
Characteristics of patients with melanoma with non‑melanoma skin cancer comorbidity: Practical implications based on a retrospective study.Oncol Lett. 2025 Mar 4;29(5):214. doi: 10.3892/ol.2025.14960. eCollection 2025 May. Oncol Lett. 2025. PMID: 40093867 Free PMC article.
-
Etiology of non-Hodgkin lymphoma: A review from epidemiologic studies.J Natl Cancer Cent. 2022 Aug 17;2(4):226-234. doi: 10.1016/j.jncc.2022.08.003. eCollection 2022 Dec. J Natl Cancer Cent. 2022. PMID: 39036553 Free PMC article. Review.
-
Covid-19, leukemia, and secondary malignancies of the skin - is there a connection: a case report and literature analysis.Front Oncol. 2023 Oct 27;13:1265479. doi: 10.3389/fonc.2023.1265479. eCollection 2023. Front Oncol. 2023. PMID: 37965467 Free PMC article.
-
Biology and Treatment Advances in Cutaneous Squamous Cell Carcinoma.Cancers (Basel). 2021 Nov 11;13(22):5645. doi: 10.3390/cancers13225645. Cancers (Basel). 2021. PMID: 34830796 Free PMC article. Review.
References
-
- Mellemgaard A, Geisler CH, Storm HH.. Risk of kidney cancer and other second solid malignancies in patients with chronic lymphocytic leukemia. Eur J Haematol 2009;53:218–22. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials